Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Asset Utilization Ratio (2022 - 2025)

Axsome Therapeutics' Asset Utilization Ratio history spans 4 years, with the latest figure at 0.94 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 37.64% year-over-year to 0.94; the TTM value through Dec 2025 reached 0.94, up 37.64%, while the annual FY2025 figure was 1.01, 52.18% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.94 at Axsome Therapeutics, up from 0.86 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.94 in Q4 2025 and bottomed at 0.1 in Q4 2022.
  • The 4-year median for Asset Utilization Ratio is 0.53 (2024), against an average of 0.56.
  • The largest annual shift saw Asset Utilization Ratio surged 359.67% in 2023 before it grew 24.86% in 2024.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.1 in 2022, then soared by 359.67% to 0.46 in 2023, then skyrocketed by 49.99% to 0.68 in 2024, then surged by 37.64% to 0.94 in 2025.
  • Per Business Quant, the three most recent readings for AXSM's Asset Utilization Ratio are 0.94 (Q4 2025), 0.86 (Q3 2025), and 0.8 (Q2 2025).